Blog Posts

Emcure Pharmaceuticals To Launch Oral Covid-19 Drug In A Week’s Time In India

Emcure Pharmaceuticals to launch oral Covid-19 drug in a week’s time in India

Emcure Pharmaceuticals Limited (EPL) announced that it has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India for the launch of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild COVID-19. EPL plans to launch Molnupiravir under the brand name Lizuvira in the Indian market.
Read more at https://www.ibgnews.com/2022/01/01/emcure-pharmaceuticals-to-launch...

Views: 0

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service